Detection Rates for Aneuploidy by First-Trimester and Sequential Screening
- PMID: 26348180
- DOI: 10.1097/AOG.0000000000001040
Detection Rates for Aneuploidy by First-Trimester and Sequential Screening
Abstract
Objective: To estimate detection rates for aneuploidy by first-trimester and sequential screening.
Methods: The study included women with singleton pregnancies who participated in the California Prenatal Screening Program with estimated delivery dates from August 2009 to December 2012 who had first- or first- and second-trimester (sequential) screening. Detection rates were measured for target (trisomies 21 and 18) and other aneuploidies identified from the California Chromosome Defect Registry.
Results: Of 452,901 women screened, 17,435 (3.8%) were screen-positive for Down syndrome only; 433 (0.1%) for trisomy 18 only; 1,689 (0.4%) for both Down syndrome and trisomy 18; and 2,947 (0.7%) for neural tube defects, Smith-Lemli-Opitz syndrome, or for multiple conditions. The detection rates were Down syndrome-92.9% (95% confidence interval [CI] 91.4-94.2); trisomy 18-93.2% (95% CI 90.5-95.9); trisomy 13-80.4% (95% CI 73.9-86.9); 45,X-80.1% (95% CI 73.9-86.3), and triploidy-91.0% (95% CI 84.2-97.9). Overall, the detection rate for chromosome abnormalities was 81.6% (95% CI 80.0-83.1) at an overall false-positive rate of 4.5%.
Conclusion: First-trimester and sequential screening are sensitive and specific for the broad range of karyotype abnormalities seen in the population.
Level of evidence: II.
References
-
- Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 77. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:217–27.
-
- Currier R, Wu N, van Meter K, Goldman S, Lorey F, Flessel M. Integrated and first trimester prenatal screening in California: program implementation and patient choice for follow-up services. Prenat Diagn 2012;32:1077–83.
-
- Kazerouni NN, Currier B, Malm L, Riggle S, Hodgkinson C, Smith S, et al.. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol 2009;114:50–8.
-
- Kazerouni NN, Currier RJ, Flessel M, Goldman S, Hennigan C, Hodgkinson C, et al.. Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. Prenat Diagn 2011;31:901–6.
-
- Wu N, Platt LD, Greene N, Currier RJ. Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance. Obstet Gynecol 2012;119:785–94.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources